We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for tagraxofusp (A Menarini Australia Pty Ltd)
Active ingredients
tagraxofusp
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Concentrate for infusion
Indication
For the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Therapeutic area
Haematology